Conor Woods

2.6k total citations · 2 hit papers
33 papers, 2.0k citations indexed

About

Conor Woods is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Conor Woods has authored 33 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Conor Woods's work include Pituitary Gland Disorders and Treatments (8 papers), Hormonal Regulation and Hypertension (8 papers) and Adrenal Hormones and Disorders (6 papers). Conor Woods is often cited by papers focused on Pituitary Gland Disorders and Treatments (8 papers), Hormonal Regulation and Hypertension (8 papers) and Adrenal Hormones and Disorders (6 papers). Conor Woods collaborates with scholars based in Ireland, United Kingdom and United States. Conor Woods's co-authors include Jeremy Tomlinson, Jonathan Hazlehurst, Thomas Marjot, Jeremy Cobbold, Elias Lazarides, Jian‐Yong Zhu, Michael Götz, Lawrence R. Koupal, Jerrold M. Liesch and Otto D. Hensens and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Cell Science and Endocrinology.

In The Last Decade

Conor Woods

30 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.

1995 535 citations Conor Woods et al. profile →
Non-alcoholic fatty liver disease and diabetes

2016 403 citations Jonathan Hazlehurst, Conor Woods et al. Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Conor Woods Ireland	17	816	567	514	411	277	33	2.0k
Margaret C. Eggo United Kingdom	34	1.4k 1.7×	374 0.7×	1.3k 2.5×	313 0.8×	247 0.9×	94	3.1k
Arya Mani United States	29	314 0.4×	381 0.7×	1.3k 2.6×	192 0.5×	486 1.8×	66	2.6k
Atsuko Nakatsuka Japan	20	448 0.5×	757 1.3×	662 1.3×	86 0.2×	390 1.4×	50	2.2k
Nicola Perrotti Italy	30	592 0.7×	195 0.3×	1.4k 2.6×	228 0.6×	352 1.3×	92	2.4k
Sabina Baumgartner‐Parzer Austria	32	752 0.9×	399 0.7×	1.2k 2.3×	237 0.6×	358 1.3×	94	2.7k
Bruno Derudas France	22	410 0.5×	1.1k 2.0×	1.6k 3.2×	326 0.8×	527 1.9×	35	3.5k
Marthe Moldes France	24	388 0.5×	659 1.2×	1.1k 2.1×	114 0.3×	365 1.3×	40	2.1k
Eiji Yoshihara Japan	22	299 0.4×	204 0.4×	1.3k 2.6×	248 0.6×	650 2.3×	54	2.3k
Andrea Hartner Germany	31	509 0.6×	152 0.3×	1.1k 2.1×	187 0.5×	275 1.0×	111	3.3k
Anna Gumà Spain	31	444 0.5×	268 0.5×	1.4k 2.7×	347 0.8×	667 2.4×	74	2.8k

Countries citing papers authored by Conor Woods

Since Specialization

Citations

This map shows the geographic impact of Conor Woods's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conor Woods with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conor Woods more than expected).

Fields of papers citing papers by Conor Woods

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conor Woods. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conor Woods. The network helps show where Conor Woods may publish in the future.

Co-authorship network of co-authors of Conor Woods

This figure shows the co-authorship network connecting the top 25 collaborators of Conor Woods. A scholar is included among the top collaborators of Conor Woods based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conor Woods. Conor Woods is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pofi, Riccardo, Thomas Marjot, Amy Barrett, et al.. (2025). Dose-dependent and tissue-specific adverse effects of exogenous glucocorticoids: insights for optimizing clinical practice. Journal of Endocrinological Investigation. 48(9). 2067–2076.

Morrison, Laura, Adam H. Dyer, Isabelle Killane, et al.. (2024). Discrete Relationships between Spatiotemporal Gait Characteristics and Domain-Specific Neuropsychological Performance in Midlife. Sensors. 24(12). 3903–3903. 1 indexed citations

Dyer, Adam H., Seán Kennelly, Sean D. Reid, et al.. (2022). Gait Characteristics and Cognitive Function in Middle-Aged Adults with and without Type 2 Diabetes Mellitus: Data from ENBIND. Sensors. 22(15). 5710–5710. 8 indexed citations

Dyer, Adam H., Isabella Batten, Liam Townsend, et al.. (2022). Neuropsychological decrements in midlife type-2 diabetes are not associated with peripheral NLRP3 inflammasome responsiveness. Frontiers in Immunology. 13. 1021351–1021351. 5 indexed citations

Dyer, Adam H., Louise McKenna, Nollaig M. Bourke, et al.. (2020). Cognitive performance in midlife type 2 diabetes: results from the ENBIND study. Diabetic Medicine. 38(6). e14412–e14412. 15 indexed citations

Marjot, Thomas, Conor Woods, Jonathan Hazlehurst, et al.. (2020). Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids. The Journal of Clinical Endocrinology & Metabolism. 105(9). e3316–e3328. 8 indexed citations

Garrahy, Aoife, Conor Woods, Rachel Crowley, et al.. (2019). The prevalence and incidence of thyroid dysfunction in patients with diabetes - a longitudinal follow-up study. Irish Journal of Medical Science (1971 -). 189(1). 171–175. 7 indexed citations

Bogdanet, Delia, Rosemary Dineen, Conor Woods, et al.. (2018). Rates of abnormal aldosterone/renin ratio in African‐origin compared to European‐origin patients: A retrospective study. Clinical Endocrinology. 90(4). 528–533. 4 indexed citations

Sbardella, Emilia, Andrea M. Isidori, Conor Woods, et al.. (2016). Baseline morning cortisol level as a predictor of pituitary–adrenal reserve: a comparison across three assays. Clinical Endocrinology. 86(2). 177–184. 61 indexed citations

10.

Hazlehurst, Jonathan, Conor Woods, Thomas Marjot, Jeremy Cobbold, & Jeremy Tomlinson. (2016). Non-alcoholic fatty liver disease and diabetes. Metabolism. 65(8). 1096–1108. 403 indexed citations breakdown →

11.

Woods, Conor, M. Corrigan, Laura Gathercole, et al.. (2015). Tissue Specific Regulation of Glucocorticoids in Severe Obesity and the Response to Significant Weight Loss Following Bariatric Surgery (BARICORT). The Journal of Clinical Endocrinology & Metabolism. 100(4). 1434–1444. 33 indexed citations

12.

Woods, Conor, Nicola Argese, Matthew Chapman, et al.. (2015). Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol. European Journal of Endocrinology. 173(5). 633–642. 110 indexed citations

13.

Woods, Conor, et al.. (2015). Glucocorticoids and non-alcoholic fatty liver disease. The Journal of Steroid Biochemistry and Molecular Biology. 154. 94–103. 134 indexed citations

14.

Woods, Conor & Jeremy Tomlinson. (2015). The Dehydrogenase Hypothesis. Advances in experimental medicine and biology. 872. 353–380. 17 indexed citations

15.

O’Shea, Donal, M. Corrigan, Margaret R. Dunne, et al.. (2013). Changes in human dendritic cell number and function in severe obesity may contribute to increased susceptibility to viral infection. International Journal of Obesity. 37(11). 1510–1513. 59 indexed citations

16.

Lewis, Heather, Mark C. Wilkinson, James T. Dalton, et al.. (2012). 1131 ACTIVE INJECTION DRUG USER'S CAN BE SUCCESSFULLY TREATED FOR HCV AND SIGNIFICANTLY REDUCE ILLICIT DRUG USE POST TREATMENT: REAL LIFE COHORT OF 152 PATIENTS. Journal of Hepatology. 56. S446–S446. 1 indexed citations

17.

Sherlock, Mark, Conor Woods, & Michael C. Sheppard. (2011). Medical therapy in acromegaly. Nature Reviews Endocrinology. 7(5). 291–300. 47 indexed citations

18.

Crowley, Rachel, Conor Woods, Mark D. Fleming, et al.. (2011). Somnolence in adult craniopharyngioma patients is a common, heterogeneous condition that is potentially treatable. Clinical Endocrinology. 74(6). 750–755. 39 indexed citations

19.

Woods, Conor & Chris Thompson. (2007). Risk of diabetes insipidus after pituitary surgery. Expert Review of Endocrinology & Metabolism. 3(1). 23–27. 10 indexed citations

20.

Heynen, G, J. A. Kanis, Conor Woods, et al.. (1976). PLASMA IMMUNOREACTIVE CALCITONIN AND BONE-DISEASE IN DIALYZED PATIENTS. Kidney International. 10. 195–195. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact